Disease × agent pairs

Long COVID / Post-Acute COVID Sequelae (PACVS): candidate agents with evidence

12 agents linked to Post-Acute COVID/Vaccination Syndrome by at least one registered trial or two publications, ranked by the OSMF evidence score. Not treatment advice.

Research Tracker › Pairs › Long COVID / Post-Acute COVID Sequelae (PACVS)
Open Long COVID / Post-Acute COVID Sequelae (PACVS) in the Repurposing ExplorerLong COVID / Post-Acute COVID Sequelae (PACVS) hub

Anakinra

Biologic · tier A · 0 trials (0 recruiting) · 15 publications · score 50.0

Nicotine

Drug · tier A · 0 trials (0 recruiting) · 14 publications · score 50.0

Remdesivir

Drug · tier A · 0 trials (0 recruiting) · 14 publications · score 50.0

Sotrovimab

Biologic · tier A · 0 trials (0 recruiting) · 12 publications · score 50.0

Tocilizumab

Biologic · tier A · 0 trials (0 recruiting) · 14 publications · score 50.0

Regdanvimab

Biologic · tier A · 0 trials (0 recruiting) · 6 publications · score 41.0

Creatine

Supplement · tier C · 0 trials (0 recruiting) · 14 publications · score 35.0

N-acetylcysteine (NAC)

Supplement · tier C · 0 trials (0 recruiting) · 7 publications · score 28.0

Tozinameran

Drug · tier A · 0 trials (0 recruiting) · 3 publications · score 28.0

Elasomeran

Drug · tier A · 1 trials (0 recruiting) · 0 publications · score 23.5

Tacrolimus Anhydrous

Drug · tier A · 1 trials (0 recruiting) · 0 publications · score 23.5

Taurine

Supplement · tier C · 0 trials (0 recruiting) · 3 publications · score 17.0

Research map, not treatment advice. Built 2026-10-07.